Corient Capital Partners’s GSK GSK Stock Holding History

Corient Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$347K	Buy
2022 Q2	$347K	Sell
2022 Q1	$383K	Buy
2021 Q4	$365K	Buy
2021 Q3	$221K	Buy
2020 Q1	–	Sell
2019 Q4	$277K	Buy
2019 Q3	$228K	Buy